MedTrace Logo

Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy

NCT03658317 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-09-14

No results posted yet for this study

Summary

diabetic nephropathy is one of the leading causes of end stage renal disease

Conditions

  • Diabetic Nephropathy

Interventions

DIAGNOSTIC_TEST

renal arterial resistive index

done by dupplex on renal arteries

DIAGNOSTIC_TEST

uric acid level

serum sample for doing the test

DIAGNOSTIC_TEST

serum urea and creatinine

serum samples for doing the test

DIAGNOSTIC_TEST

24 hours urinary proteins

urine collected over 24 hours for doing the test

DIAGNOSTIC_TEST

lipogram

serum sample for doing the test

DIAGNOSTIC_TEST

HbA1c level

serum sample for doing the test

DIAGNOSTIC_TEST

urine analysis

urine sample for doing the test

DIAGNOSTIC_TEST

abdominal ultrasonography

done by the ultrasonography device

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2019-03-31
Completion
2019-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658317 on ClinicalTrials.gov